Diseases, Conditions, Syndromes

Endogenous infection marker guides antibiotic therapy

The endogenous infection marker procalcitonin can help to guide the use of antibiotics when treating infections. The course of antibiotic therapy is shortened, and its side effects and mortality rate also decrease, as researchers ...

Diseases, Conditions, Syndromes

Freeing up hospital beds—how children can leave hospital sooner

Experts have found that some children with severe infections requiring intravenous (through the vein) (IV) antibiotics, can safely have these at home instead of in hospital. This will help children to leave hospital earlier, ...

Diseases, Conditions, Syndromes

Review: Killed whole-cell oral cholera vaccine efficacious

(HealthDay)—Two doses of killed whole-cell oral cholera vaccine (kOCV) are efficacious for protecting against cholera for at least two years after vaccination, according to a review published online July 17 in The Lancet ...

Diseases, Conditions, Syndromes

Multidrug-resistant TB set to increase through 2040

(HealthDay)—Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are expected to increase through 2040, according to a study published online May 9 in The Lancet Infectious Diseases.

page 6 from 18